GlyCosmos Portal

GlyCOVID

GlyCOVID is a dataset of RDFized COVID-19 data related to glycans. Resources will be added incrementally as publications are curated.

Longitudinal Development of Antibody Responses in COVID-19 Patients of Different Severity with ELISA, Peptide, and Glycan Arrays: An Immunological Case Series.
Heidepriem J, et al.
Pathogens. 2021; 10(4):438. https://doi.org/10.3390/pathogens10040438

A longitudinal analysis of three COVID-19 patients with moderate (#1) and mild disease (#2 and #3) was published. Antibody serum responses were analyzed using spike glycoprotein enzyme linked immunosorbent assay (ELISA), full-proteome peptide, and glycan microarrays. In this Glycovid dataset, the data from these glycan microarray experiments have been RDFized. Fluorescence intensity is given in arbitrary fluorescence units (AFU) as reported in this publication.

Source	Last Updated
PSICQUIC	March 30, 2022

Displaying entries **2951 - 2975** of **4050** in total

« First

‹ Prev

…

115

116

117

118

119

120

121

122

123

…

Next ›

Last »
Antibody	Patient	Onset (days)	Symptom	GlyTouCan ID ▼	Arbitrary Fluorescence Units (AFU)
IgA	Patient 2	24	mild	G21460SG	380
IgG	Patient 2	15	mild	G21460SG	345
IgG	Patient 2	24	mild	G21460SG	284
IgM	Patient 2	15	mild	G21460SG	155
IgM	Patient 2	24	mild	G21460SG	153
IgA	Patient 2	3	mild	G21460SG	405
IgG	Patient 2	3	mild	G21460SG	607
IgM	Patient 2	3	mild	G21460SG	242
IgA	Patient 3	-180	mild	G21460SG	255
IgA	Patient 3	11	mild	G21460SG	451
IgG	Patient 3	-180	mild	G21460SG	46
IgM	Patient 3	-180	mild	G21460SG	93
IgA	Patient 3	4	mild	G21460SG	506
IgG	Patient 3	11	mild	G21460SG	99
IgG	Patient 3	4	mild	G21460SG	88
IgM	Patient 3	11	mild	G21460SG	92
IgM	Patient 3	4	mild	G21460SG	77
IgA	Patient 4	12	mild	G21460SG	386
IgG	Patient 4	12	mild	G21460SG	74
IgM	Patient 4	12	mild	G21460SG	163
IgA	Patient 1	10	moderate	G21320TF	393
IgA	Patient 1	22	moderate	G21320TF	394
IgA	Patient 1	6	moderate	G21320TF	286
IgG	Patient 1	10	moderate	G21320TF	23
IgG	Patient 1	22	moderate	G21320TF	33